Pharma / Medical

The Industrial Parks Development Corporation (IPDC) was established in December 2014 as a public enterprise tasked with advancing Ethiopia's industrialization by providing integrated infrastructure for both domestic and foreign investors. IPDC has developed and currently manages 10 special economic zones, 2 industrial parks and one Free Trade Zone across Ethiopia. These special economic zones are strategically positioned along the country's major development corridors, taking into account transportation links and resource hubs. With full government support, IPDC is emerging as a key driver of rapid industrialization, fostering manufacturing industries, accelerating economic transformation, and promoting investment opportunities for both local and international investors. To streamline both pre- and post-investment processes, IPDC offers serviced industrial land, pre-built factory sheds with comprehensive utilities, and infrastructure that meets international standards. In partnership with the Ethiopian Investment Commission, Ministry of Revenue, Customs Authority, Immigration and Nationality Service, and other key stakeholders, IPDC delivers a seamless investment experience through a one-stop-shop service for investors aiming to establish operations in its world-class industrial parks. Recently, the Ethiopian Investment Board designated 11 of the 13 parks developed and managed by IPDC as Special Economic Zones (SEZs), further enhancing their appeal to investors.

Ethiopian Pharmaceuticals Supply Agency, EPSA, is legal entity established under the law of Federal Democratic Republic of Ethiopia Government to overcome the problems and assure uninterrupted supply of pharmaceuticals to the public at an affordable price. The main task of EPHARMECOR was to distribute human, animal and plant pharmaceuticals and medical supplies it manufactured and imported from abroad. However, the steady plunge in the corporation’s capital and the subsequent weakened supply necessitated another restructuring which came during the period of the transitional government in 1994. Accordingly, the transitional government allocated a huge budget to bridge the pharmaceutical gap and restructured EPHARMECOR into a new organization called Pharmaceutical and Medical Supplies Importer and wholesale Distributor (PHARMED). PHARMED had over 400 workers back then and distributed two-hundred eighty million birr worth of Pharmaceuticals and medical supplies primarily to governmental health institutions. Seeking to ensure the organization fulfils its mission optimally, it was restructured eight years later, in 2002, as a share company that distributes pharmaceuticals and medical supplies purchased locally and from overseas. Taking the changes in the sector into consideration, PHARMED was once again re-established with reformed vision, mission and goals in 2007 under proclamation No. 553/2007 bearing the name “Pharmaceutical Fund and Supply Agency (PFSA).” PFSA is structured to sustainably supply basic pharmaceuticals used for treating the main health problems in the country along with medical equipment and to consider the purchasing capacity of the society in providing its services. PFSA has once again changed its name at the beginning of the 2019 to “Ethiopian Pharmaceuticals Supply Agency(EPSA).” Despite the changes in organizational structure, naming and goal throughout its history, the institution’s primary activity has always been supplying pharmaceuticals and medical equipment mainly to governmental health institutions.The Pharmaceuticals Fund and Supply Agency was established in September 2007 by Proclamation No. 553/2007 as part of Pharmaceutical Logistic Master Plan implementation with the following objectives: i. To enable public health institutions to supply quality assured essential pharmaceuticals at affordable prices in a sustainable manner to the public; ii. To play a complementary role in developmental efforts for health service expansion and strengthening by ensuring enhanced and sustainable supply of pharmaceuticals; iii. To create enabling conditions for enhancing the accumulation of funds in its revolving and cost recovery process and thereby ensure the realization of the objectives We are the most responsive and efficient pharmaceutical supply chain organization in Africa  

We are a prominent supplier of pharmaceuticals, nutraceuticals, and medical supplies in Ethiopia, with an aim of local pharmaceutical manufacturing and provide superior quality agricultural products to global markets and reliable pharmaceutical, nutraceutical, and medical supply solutions to Ethiopia , while adhering to ethical and sustainable business practices.

Caroga Pharma Ethiopia is one of the leading pharmaceutical importers and distrinbutors of Ethiopia representing the five largest pharmaceutical companies in the world amongst others Pfizer, Merck, Novartis, Abbot and Rosche. We provide high quality medical supplies at the most affordable price to cover the needs of both the private and public health sectors of Ethiopia. Established 25 years ago in Addis Ababa, Caroga Pharma is a sub distributor that covers all the main regional capitals of the Federal Republic of Ethiopia. Today, it enjoys a solid reputation amongst the peers, clients and principals for its very high quality standards and service delivery built on years of collaboration with the communities and its stake holders around Ethiopia. Caroga Pharma has received various recognitions and awards in 2007 and the best Ethical Marketer in 2015 and 2016 from Novartis.

Dawa Mkononi is focused on using innovation to improve the supply chain. Dawa Mkononi's operations mainly target pharmacies, health facilities, and other registered B2B clients. With its data-driven approaches, we have a mission of improving access to medicine distribution and making medicines more available to health facilities. Dawa Mkononi is a product of DMRX Inc., a United States of America-based Company. DMRX Inc. is the holding company of DMRX Company Limited, a company incorporated in Tanzania.